William John Sibold, CEO of Madrigal Pharmaceuticals MDGL, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $2.9M. The latest trade was on 03/06.

WS

WS

William John Sibold

President and CEO

Company

Madrigal Pharmaceuticals MDGL

First filing

23/09/13

Trades

21 trades

Buys / sales

0 / 8

12-month net buying

−$2.9M

Last trade

03/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Madrigal PharmaceuticalsMDGL	Open-market sale	03/06	03/06	1,663 sh	$431.94	$718,316.22	−1.0%
Madrigal PharmaceuticalsMDGL	Open-market sale	01/26	01/26	1,577 sh	$492.42	$776,546.34	−1.1%
Madrigal PharmaceuticalsMDGL	Open-market sale	25/12/04	25/12/04	2,400 sh	$575.34	$1,380,816	−1.6%
Madrigal PharmaceuticalsMDGL	Open-market sale	25/09/09	25/09/09	7,279 sh	$445.63	$3,243,740.77	−6.6%
Madrigal PharmaceuticalsMDGL	Open-market sale10b5-1 plan	25/08/21	25/08/21	7,616 sh2 trades	$400.17avg.	$3,047,725.55	−6.5%
Madrigal PharmaceuticalsMDGL	Open-market sale	25/01/24	25/01/27	1,584 sh	$335.24	$531,020.16	−2.8%
Madrigal PharmaceuticalsMDGL	Open-market sale	24/09/09	24/09/11	6,363 sh	$243.83	$1,551,490.29	−10.2%